Atorvastatin is HMG-CoA reductase inhibitor indicated as an adjunct therapy to diet to:
reduce risk of MI, stroke, revascularization procedures, and angina in adult patients without CHD, but with multiple risk factor.
reduce the risk of MI and stroke in adult patients with type 2 diabetes without CHD, but with multiple risk factors.
reduce the risk of non-fatal MI, fatal and non-fatal stroke, revascularization procedures, hospitalization for CHF, and angina patients with CHD.
Following information see from leaflet inside the pack:
Mechanism of action, Pharmacokinetics, Administration, Dosing consideration in special populations, contraindications, warinings and precautions, adverse ractions, drug interations, use in special population, overdosage.
